Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: Mov Disord. 2019 Jan;34(1):58–66. doi: 10.1002/mds.27577

TABLE 1.

Characteristics of the patient cohort

Lifestyle factor distribution by median level
Characteristic Mean (SD) or n (%) Duration (y) Never <Median ≥Median
PD patient cohort (n = 244)
 Age at diagnosis 66.9 (9.9)
 Sex, male 139 (57)
 European ancestry 195 (80)
 PD duration, baseline exam (y) 2.1 (1.5)
 Follow-up, years 5.3 (2.1)
 Years of schooling 13.7 (4.4)
 Caffeinated coffee 40.1 (19.8) 34 (14) 104 (43) 106 (43)
 Caffeinated tea 31.1 (23.3) 67 (27) 80 (33) 93 (39)
 Alcohol, ever 221 (91)
 Alcohol, weekly 159 (65)
 Beer (drinks/day) 21.9 (21.4) 94 (39) 80 (33) 70 (29)
 Wine (drinks/day) 20.1 (20.4) 104 (43) 67 (28) 72 (30)
 Liquor (drinks/day) 21.2 (21.2) 102 (42) 74 (30) 68 (28)
 Physical activity, MET-h/wk (IQR) 1.01 (1.2) N/A 126 (53) 113 (47)
 Competitive sports, ever 117 (49)
 Smoking, never 133 (55)
  Former 101 (41)
  Current (at baseline) 10 (4)
 Pack-years 9.4 (19.6)
MMSE cognition score (n = 242)
 Mean change on MMSE, per 5 years −1.3 (4.8)
 Cognitive decline (≥4 points in score) 50 (21)
  Observed time from baseline exam (y)a 5.1 (2.2)
  Mean change on MMSE, per 5 years among those with cognitive decline −6.4 (7.1)
Hoehn & Yahr (n = 243)
 Baseline H&Y ≥ 3 31 (13)
 Conversion from <3 to ≥3 77 (32)
  Observed time from baseline exam (y)a 4.7 (2.0)
Survival
 Registered deaths — PD patients (n = 360) 209 (58)
  Age at death/censor (y) 78.3 (9.1)
 Registered deaths — controls (n = 341) 67 (20)
  Age at death/censor (y) 78.7 (11.5)

MMSE, Mini-Mental State Exam; H&Y, Hoehn & Yahr score; N/A, not applicable.

a

Observed time to event or censor, excluding those with event at baseline